ArticleScientific reports2019

Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.

Phuong Tran Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.